Company Overview
About Harpoon Therapeutics
Harpoon Therapeutics is an immuno-oncology company focused on developing novel biologics for cancer treatment using its proprietary TriTAC technology platform. The company's approach aims to harness the power of a patient's own immune system to target and kill cancer cells. Harpoon Therapeutics has recently been acquired by Merck, further expanding the company's capabilities and pipeline in the field of oncology.
;%20fill-rule:%20evenodd;%20}%20.cls-2%20{%20fill:%20none;%20}%20%3c/style%3e%3clinearGradient%20id='linear-gradient'%20x1='-1275.62'%20y1='432.1'%20x2='-1272.18'%20y2='427.35'%20gradientTransform='translate(30659%2010381.36)%20scale(24%20-24)'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20offset='0'%20stop-color='%2325c5ff'/%3e%3cstop%20offset='.45'%20stop-color='%230048ff'/%3e%3cstop%20offset='1'%20stop-color='%23c500f3'/%3e%3c/linearGradient%3e%3c/defs%3e%3cpath%20class='cls-2'%20d='M0,0H150V150H0V0Z'/%3e%3cg%20id='Layer_2'%20data-name='Layer%202'%3e%3cg%20id='Layer_1-2'%20data-name='Layer%201-2'%3e%3cg%20id='Artboard'%3e%3cg%20id='userway_logo'%20data-name='userway%20logo'%3e%3cpath%20id='Combined-Shape'%20class='cls-1'%20d='M18.75,36.94c5.16-.03,9.36,4.13,9.39,9.28,0,.03,0,.07,0,.1h0v7.3h0v23.47c0,26.79,21.71,48.5,48.5,48.5s48.5-21.71,48.5-48.5h0v-23.99h0v-7.3c-.03-5.16,4.13-9.36,9.28-9.39,.03,0,.07,0,.1,0h4.69v40.68c0,34.56-28.02,62.58-62.58,62.58S14.06,111.66,14.06,77.1h0V36.94h4.69Zm2.09-22.42c16.1-.03,29.18,13,29.2,29.1,0,.03,0,.07,0,.1v33.38c0,14.69,11.91,26.6,26.6,26.6s26.6-11.91,26.6-26.6V43.72c-.03-16.1,13-29.18,29.1-29.2,.03,0,.07,0,.1,0h6.78v14.08h-6.78c-8.35,0-15.12,6.77-15.12,15.12v33.38c0,22.18-17.98,40.16-40.16,40.16h0c-22.28,.03-40.42-17.88-40.68-40.16V43.72c-.08-8.44-6.99-15.21-15.43-15.13-.07,0-.14,0-.21,0h-6.78V14.52h6.78Z'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
